4//SEC Filing
KalVista Pharmaceuticals, Inc. 4
Accession 0001140361-17-013500
$KALVCIK 0001348911operating
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 7:08 PM ET
Size
6.3 KB
Accession
0001140361-17-013500
Insider Transaction Report
Form 4
Resnick Joshua
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2017-03-23+12,000→ 12,000 totalExercise: $7.88Exp: 2027-03-22→ Common Stock (12,000 underlying)
Footnotes (2)
- [F1]The option vests over a 3 year period: 1/36th on December 21, 2016, after which 1/36th of the total shares vest monthly, subject to continued service through each vesting date.
- [F2]The option is held by the reporting person for the benefit of SV Life Sciences Advisers, LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
KalVista Pharmaceuticals, Inc.
CIK 0001348911
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001348911
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 7:08 PM ET
- Size
- 6.3 KB